New vaccines created by Johnson & Johnson and Novavax are showing promising results in reducing illness caused by the coronavirus, though they were less effective than other vaccines and against some virus variants, which are causing growing concerns. White House correspondent Yamiche Alcindor reports.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts